Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20180614004
TCTR20180614004
Active, not recruiting
未知

A randomized, placebo controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis

ONE0 sites34 target enrollmentJune 14, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsModerate to severe obstructive sleep apnea with chronic rhinitisModerate to severe obstructive sleep apneachronic rhinitisapnea hypopnea indexintranasal steroid

Overview

Phase
未知
Intervention
Not specified
Conditions
Moderate to severe obstructive sleep apnea with chronic rhinitis
Sponsor
ONE
Enrollment
34
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2018
End Date
June 1, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ONE

Eligibility Criteria

Inclusion Criteria

  • •1\. 20\-65 year old volunteers
  • •2\. Polysomnography test with apnea\-hypopnea index at least 15 events per hour
  • •3\. Total nasal symptom score questionnaire required more than 6
  • •4\. Skin test required
  • •5\. Modified Mallampati grade 1\-2

Exclusion Criteria

  • •1\. Without serious co\-morbidity disease; resistant hypertension, poor controlled cardiovascular disease, cerebrovascular disease
  • •2\. Morbid obesity; body mass index was more than 30 kg/m2
  • •3\. Oral appliance or continue positive airway pressure previous used
  • •4\. Bi\-level positive airway pressure used
  • •5\. Previous intranasal steroid used within 3 months of research period
  • •6\. Could not attend 2 appointments and poor technique of drug used
  • •7\. Could not discontinue anti\-allergy drug within 7 days of before enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Smoking cessatio
EUCTR2012-002731-28-PLBioprojet250
Active, not recruiting
Not Applicable
Smoking cessatioSmoking cessationMedDRA version: 16.1Level: LLTClassification code 10008374Term: Cessation of smokingSystem Organ Class: 100000004869Therapeutic area: Psychiatry and Psychology [F] - Behaviours [F01]
EUCTR2012-002731-28-CZBioprojet350
Not yet recruiting
Phase 2
Clinical study on the effect of Navayas Lauha (an ayurvedic classical formulation) and specific diet in the management of obesity(sthaulya)
CTRI/2024/02/062731G J Patel Institute of Ayurvedic Studies and Research
Active, not recruiting
Phase 4
Is pramipexole effective as an add-on treatment for people with treatment-resistant depression?
ISRCTN84666271niversity of Oxford178
Completed
Not Applicable
A randomized placebo controlled clinical trial of a rehabilitation programme for patients with a diagnosis of massive, irreparable rotator cuff tears of the shoulder
ISRCTN64734872Record Provided by the NHSTCT Register - 2006 Update - Department of Health60